Navigation Links
Isis Pharmaceuticals And AstraZeneca Form Strategic Alliance On RNA Therapeutics For Cancer
Date:12/11/2012

CARLSBAD, Calif., Dec. 11, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and AstraZeneca announced today a strategic alliance for the discovery and development of novel generation antisense therapeutics against five cancer targets, which includes a license to develop and commercialise ISIS-STAT3Rx, a drug Isis is currently evaluating in an early clinical trial in patients with advanced lymphomas. Antisense therapies target the proteins involved in disease processes by destroying the RNA that is involved in creating these proteins. The Isis discovery platform develops specific therapies that bind to messenger RNA (mRNA) and inhibit the production of disease-causing proteins.

The strategic alliance aims to apply AstraZeneca's experience in developing personalised medicines to enhance the drug discovery and development process for four research programs in the oncology area and to aid in the development of ISIS-STAT3Rx for patient populations that could benefit the most from inhibition of STAT3, a protein that drives cancer growth. The combination of Isis' antisense technology and its new Generation 2.5 chemistry, which increases the potency of its therapeutics, provides AstraZeneca the opportunity to develop drugs that could be much more effective in cancers that are difficult to address with conventional small molecules or antibodies.

"Isis' antisense technology platform allows AstraZeneca to broaden our oncology research efforts beyond traditional drug discovery methods, while at the same time becoming more specific about how we target cancer," said Susan Galbraith, head of the AstraZeneca Oncology Innovative Medicines Unit. "AstraZeneca's expertise in oncology translational science and our global capabilities in development and commercialisation of oncology products and Isis' innovative approach to discovering novel medicine
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders
2. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
3. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
5. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
6. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
7. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
8. Additional Clinical Data from Two Trials on Actinium Pharmaceuticals Iomab-B to be Presented at American Society of Hematology (ASH) Annual Meeting
9. Salix Pharmaceuticals Donates $500,000 To ASGEs IT&T Capital Campaign To Build A New State-of-the-Art GI Training Center
10. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
11. Double-digit Growth Rate of the Pharmaceuticals Industry in Asia Pacific Boosts the API Market, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... NEWTON, Mass. and JERUSALEM, Israel, Aug. 31, 2015 ... U.S. late-stage biopharmaceutical company developing octreotide capsules for ... for the second quarter ended June 30, 2015 ... past few months have been a transformative time ... public offering and recently announced that our first ...
(Date:8/31/2015)... 31, 2015  Daktari Diagnostics today announced a collaboration with ... and Canada , to develop ... worth up to $8.5 million over the next 3.5 years, ... and regulatory approval of Daktari,s HCV test. ... that can detect low levels of virus directly in a ...
(Date:8/31/2015)... , Aug. 31, 2015 The Wolf ... statewide since Pennsylvania State Police ... drug kits, naloxone. Heroin and opioid overdose ... Pennsylvania , killing more individuals than those ... 2,400 Pennsylvanians died from a drug overdose. ...
Breaking Medicine Technology:Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 2Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 3Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 4Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 5Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 6Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 7Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 8Chiasma Reports Second Quarter 2015 Financial Results and Recent Business Highlights 9Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3
... 15, 2011 This week, university hospital ... is the first hospital in the world to operate ... technology is hoped to provide surgeons with the best ... precise and safer interventions, and offering improved patient outcomes ...
... Researchers to save and organize content for mobile ... a world-leading provider of scientific, technical and medical information products ... RACK app on SciVerse Applications . Developed by ... users to save PDFs of interest in SciVerse for further ...
Cached Medicine Technology:World's First Curve™ Image Guided Surgery System Now Operating in Germany 2World's First Curve™ Image Guided Surgery System Now Operating in Germany 3Amphetamobile Develops AMMO RACK App for SciVerse Applications 2Amphetamobile Develops AMMO RACK App for SciVerse Applications 3Amphetamobile Develops AMMO RACK App for SciVerse Applications 4
(Date:8/31/2015)... Clarkston, Metamora, Michigan (PRWEB) , ... August 31, ... ... has launched a new weight management program that is unique to the Lake ... programs in Oakland and Macomb County. , WEmovestrong’s weight management program will ...
(Date:8/31/2015)... ... 31, 2015 , ... CareSource, a nonprofit Ohio-based health plan, ... capacity, Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications and ... have contributed to the company’s rapid growth. As the CareSource business model expands ...
(Date:8/31/2015)... BAY PINES, FL (PRWEB) , ... August 31, 2015 , ... ... accessible, high quality healthcare to Veterans residing across southwest Florida by hiring more doctors ... added to the list of expanded services. , In early July, Dr. Anthony Jabre ...
(Date:8/31/2015)... ... September 01, 2015 , ... Neuropsychiatric Disease ... with emphasis on transcranial near-infrared laser phototherapy ”. , As corresponding author Dr ... been largely untreatable - with mostly palliative treatments only - and now we ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Since 1946, the ... dental care. From the moment a patient arrives at the office, the staff ... will work with each and every patient to create a complete dental treatment plan ...
Breaking Medicine News(10 mins):Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 2Health News:Near-Infrared Laser Phototherapy for Brain Injury published by Dove Medical Press 3Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2
... , FRIDAY, March 25 (HealthDay News) -- Researchers ... that live in the intestine, leading to immune system problems. ... bacteria, said the team at Ohio State University. The communities ... of potentially harmful bacteria. The study is published in ...
... The AACR would like to congratulate its newest grant ... April 2-6. Grant details and recipients are detailed ... Fellowships in Clinical/Translational Cancer Research , Takashi Kobayashi, M.D., ... invasive bladder cancer, Kun Wang, Ph.D., University of Kansas ...
... The Fifth Annual AACR Team Science Award ... renowned molecular biologists, epidemiologists, biostatisticians and clinicians from ... Washington who have worked together on human papillomavirus ... award recognizes an outstanding interdisciplinary research team for ...
... Sinai School of Medicine have discovered a way that ... most common inherited form of Parkinson,s disease. The study, ... of Science, shows that upon specific modification called phosphorylation, ... 14-3-3, which has a regulatory function inside cells. When ...
... -- Teens whose mothers drank alcohol regularly throughout the ... of developing severe behavior problems, a new study warns. ... Medicine and Medical Center analyzed data collected from 592 ... four and seven months pregnant and shortly after childbirth ...
... , PHILADELPHIA - Researchers at the University of Pennsylvania,s ... treating pancreatic cancer by activating the immune system to ... a small cohort of patients with advanced pancreatic cancer, ... their findings and the novel way in which ...
Cached Medicine News:Health News:AACR recognizes its newest grantees at 102nd Annual Meeting 2011 2Health News:Research team honored for innovative science to advance cancer research 2Health News:Research team honored for innovative science to advance cancer research 3Health News:Mount Sinai finds promising clue to mechanism behind gene mutation that causes Parkinson's disease 2Health News:Prenatal Alcohol Exposure Linked to Behavior Problems in Teens 2Health News:Penn researchers uncover novel immune therapy for pancreatic cancer 2Health News:Penn researchers uncover novel immune therapy for pancreatic cancer 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: